XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | nl | no | nz | pt | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US, Authority Hl7

16,284 resources

By Version

R2: 52
R2B: 0
R3: 523
R4: 15,269
R4B: 0
R5: 440
R6: 0

Start Prev Rows 7600 - 7800 Next

Package	Version	Identity	Name/Title	Status	Date
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2247	Extrapulmonary [NTM] (Specimen Type) (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2248	Plasmodium species (Tests by Microscopic Observation)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2249	Baylisascariasis (Tests for Baylisascaris species Antibody in Serum or CSF)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2250	Lower Respiratory [Excluding Sputum] (Specimen Type) (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2251	Organisms (Tests in Sputum Specimen by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2252	Organisms (Tests in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2253	Organisms (Tests for Nucleic Acid in Lower Respiratory Specimen [Including Sputum] )	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2254	Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2255	Carbapenem Resistant Bacterial Infection [Carbapenemase Producing] (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2256	CP_CRE (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2257	Organisms (Tests in Stool by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2258	Loss of Consciousness (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2259	Neonatal Abstinence Syndrome (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2260	Neonatal Abstinence Syndrome (Disorders) (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2261	High Pitched Cry (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2262	Inability to Console (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2263	Inability to Console (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2264	Hypertonia (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2265	Hypertonia (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2266	Tremors (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2267	Tremors (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2268	Myoclonus (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2269	Myoclonus (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2270	Poor Sleep (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2271	Poor Sleep (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2272	Alterations in Feeding (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2273	Alterations in Feeding (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2274	Excoriation (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2275	Excoriation (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2276	Sneezing (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2277	Sneezing (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2278	Nasal Congestion (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2279	Nasal Congestion (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2280	Yawning (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2281	Cutaneous Mottling (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2282	Sweating (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2283	Sweating (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2284	Feeding Intolerance (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2285	Feeding Intolerance (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2286	Respiratory Distress or Nasal Flaring (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2287	Respiratory Distress or Nasal Flaring (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2288	In Utero Exposure to Opioids, Benzodiazepines, or Barbiturates (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2289	In Utero Substance Exposure (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2290	In Utero Substance Exposure (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2291	Childbirth (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2292	Childbirth (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2293	Opioids, Benzodiazepines, or Barbiturates (Tests by Any Method)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2294	NonOpioid, NonBenzodiazepine, and NonBarbiturate Substances (Tests by Any Method)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2295	Opioids, Benzodiazepines, or Barbiturates (Organism or Substance in Lab Results)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2296	NonOpioid, NonBenzodiazepine, or NonBarbiturate Substances (Organism or Substance in Lab Results)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2297	Exposure or suspected exposure to harmful algae or algae toxins (SNOMED)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2298	Exposure or suspected exposure to harmful algae or algae toxins (ICD10CM)	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2299	Group A Streptococcus (Tests for Group A Strep in Specimen from Normally Sterile Site by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2300	Babesia species (Tests by Microscopic Observation)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2301	Babesia species (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2302	Babesia species (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2305	Gram_negative Diplococcus (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2306	Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Culture and Identification Method)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2307	D_Transposition of the Great Arteries (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2308	L_Transposition of the Great Arteries (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2309	Transposition of the Great Arteries [Unspecified] (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2310	Transposition of the Great Arteries [Unspecified] (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2311	Interrupted Aortic Arch (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2312	Interrupted Aortic Arch (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2313	Coarctation of the Aorta (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2314	Coarctation of the Aorta (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2315	Ebstein Anomaly (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2316	Ebstein Anomaly (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2317	Pulmonary valve atresia (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2318	Pulmonary valve atresia (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2319	Pulmonary valve stenosis (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2320	Pulmonary valve stenosis (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2321	Fetal Pulmonary valve stenosis (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2322	Double Outlet Right Ventricle (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2323	Double Outlet Right Ventricle (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2324	Hypoplastic left heart syndrome (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2325	Hypoplastic left heart syndrome (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2326	Single Ventricle (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2327	Single Ventricle (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2328	Tetralogy of Fallot (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2329	Tetralogy of Fallot (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2330	Truncus Arteriosus (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2331	Truncus Arteriosus (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2332	Atrioventricular septal defect (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2333	Atrioventricular septal defect (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2334	Total Anomalous Pulmonary Venous Connection (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2335	Total Anomalous Pulmonary Venous Connection (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2336	Tricuspid valve atresia (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2337	Tricuspid valve atresia (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2338	Tricuspid valve stenosis (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2339	Tricuspid valve stenosis (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2340	Fetal Tricuspid valve stenosis (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2341	Exposure to Measles (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2342	Increased Risk for Exposure to Measles (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2343	Giardiasis (Tests by Microscopic Observation)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2344	Diphtheria (Tests for Diphtheria Toxin Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2345	Lead in Blood (Tests for Lead in Venous Blood)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2346	Lead in Blood (Tests for Lead in Capillary Blood)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2347	Opioid Overdose and Poisoning (Test Panels for Opioids)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2348	Rubella (Test Panels for rubella virus IgM Antibody)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2349	Consistent with Tuberculosis (Finding in Chest Xray Imaging Results)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2350	Acute Viral Hepatitis (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2351	Shigellosis (Combination Tests that include Shigella species by Culture and Identification)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2352	Acid Fast Bacilli (Tests by Microscopic Observation by Fite Stain)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2353	Acid Fast Bacilli (Tests by Microscopic Observation in Skin or Unspecified Tissue by Fite Stain)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2354	Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2355	Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain in Skin)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2356	Skin (Specimen Type) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2357	Organisms (Tests by Microscopic Observation in Skin)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2358	Unspecified Tissue (Specimen Type) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2360	S. Paratyphi Infection (Tests for S. Paratyphi by Culture and Identification Method)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2361	S. Paratyphi Infection (Tests for S. Paratyphi Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2368	Perinatal Hepatitis B (Maternal Hepatitis B Virus Infection) (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2369	Necrotizing Fasciitis (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2370	Necrotizing Fasciitis (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2371	Renal Impairment [Acute or Unspecified] (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2372	Renal Impairment [Acute or Unspecified] (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2373	Coagulopathy [Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2374	Coagulopathy [Unspecified Cause] (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2375	Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2376	Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2377	Soft Tissue Necrosis (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2378	Soft Tissue Necrosis (ICD10CM)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2379	Group A Streptococcus (Tests for Group A Strep in Specimen from Nonsterile Site by Culture and Identification Method)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2380	Organisms (Tests in Specimen from Nonsterile Site by Culture and Identification)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2381	Specimen from a Nonsterile Site (Specimen Type) (SNOMED)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2382	Chagas Disease (Tests for Trypanosoma cruzi in specimen from donor)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2383	Absence of Skin Lesions (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2384	Neuralgia (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2385	Neuralgia (ICD10CM)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2386	Peripheral Nerve Thickening (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2387	Nerve (Specimen Type) (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2388	Hansen’s Disease (Tests for M. leprae or M. lepromatosis Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.239	Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Nucleic Acid)	active	2023-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.240	Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Antigen)	active	2023-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2403	NU_Hepatitis D Virus Infection (Tests for hepatitis D virus Antibody)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2404	Hepatitis D Virus Infection (Tests for hepatitis D virus IgG Antibody)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2405	Hepatitis D Virus Infection (Test for hepatitis D virus Antigen)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2406	Hepatitis B Virus Infection (Combination Tests that include hepatitis B virus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2407	Firearm Injury (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2408	Firearm Injury (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2409	Babesiosis (Tests for B. microti IgG or Total Antibody [Titer])	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2410	Babesiosis (Tests for B. divergens IgG or Total Antibody [Titer])	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2411	Babesiosis (Tests for B. duncani IgG or Total Antibody [Titer])	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2412	Babesiosis (Tests for Babesia species IgG or Total Antibody)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2413	Brucellosis (Tests for Brucella species IgG Antibody by ELISA)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2414	Cranial Nerve Involvement (ICD10CM)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2415	Cranial Nerve Involvement (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2416	Unusual Change in Behavior (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2417	Radiculitis (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2418	Subarachnoid Hemorrhage (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2419	Subarachnoid Hemorrhage (ICD10CM)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2420	Discitis (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2421	Discitis (ICD10CM)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2423	Respiratory Insufficiency [Unspecified Cause] (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2424	Respiratory Insufficiency [Unspecified Cause] (ICD10CM)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2425	Conjunctival Suffusion (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2426	Leptospira species (Tests by Microscopic Observation)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2427	Leptospirosis (Tests for Leptospira Antibody by Agglutination)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2428	Leptospirosis (Tests for Leptospira Antibody by Indirect Immunofluorescence)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2429	Conjunctival Suffusion (ICD10CM)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2430	Pleural effusion (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2431	Pleural effusion (ICD10CM)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2432	Abdominal swelling (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2433	Abdominal swelling (ICD10CM)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2434	Neck swelling (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2435	Neck swelling (ICD10CM)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2436	Diaphoresis (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2437	Diaphoresis (ICD10CM)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2438	Edema (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2439	Edema (ICD10CM)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.244	Gonorrhea (Tests for Neisseria gonorrhoeae Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2440	Anthrax (Tests for Bacillus anthracis Protective Antigen Antibody)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2441	Anthrax (Tests for Bacillus species by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2442	Anthrax [Anthrax toxin lethal factor] (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2443	Influenza A (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2444	Influenza B (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2445	Influenza [Unspecified] (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2446	Influenza A (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2447	Influenza [Unspecified] (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2448	Influenza (Tests for unspecified influenza virus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2449	Influenza (Tests for influenza B virus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2450	Influenza (Tests for unspecified influenza virus Antigen)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2451	Influenza (Tests for influenza B virus Antigen)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2452	Influenza (unspecified influenza virus in Lab Results)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2453	Influenza (influenza B virus in Lab Results)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2454	Influenza (Tests for unspecified influenza virus by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2455	Influenza (Tests for influenza B virus by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2456	Hepatitis B Virus Infection (Tests for Hepatitis B Virus Total Core Antibody)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2457	Hepatitis C Virus Infection (Combination Tests that include hepatitis C virus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2458	Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2459	Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid in Blood)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2460	Borrelia species (Tests by Microscopic Observation)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2461	Borrelia species (Tests by Microscopic Observation in Blood)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2462	Spirochetes (Tests by Microscopic Observation)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2463	Carbapenem Resistant Enterobacterales (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2464	CP_ Carbapenem Resistant Enterobacterales (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2465	CRE (Tests for Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2466	CRE (Tests for Proteus spp., Providencia spp., and Morganella spp. by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2467	CRE (Tests for Enterobacterales species Nucleic Acid)	active	2025-02